Table 1. Clinical characteristics.
Overall | Men | Women | P | |
Number of subjects | 10,253,085 | 5,760,643 (56.18) | 4,492,442 (43.82) | <0.001 |
Age (years) | 46.86±13.83 | 45.12±13.40 | 49.10±14.05 | <0.001 |
Hypertension (%) | 238,989 (2.33) | 123,447 (2.14) | 115,542 (2.57) | <0.001 |
Body mass index (kg/m2) | 23.88±3.23 | 24.28±3.07 | 23.46±3.36 | <0.001 |
Waist circumference (cm) | 80.67±9.02 | 83.80±7.83 | 76.66±8.84 | <0.001 |
TC (mg/dL) | 195.84±35.82 | 194.43±35.08 | 197.52±36.67 | <0.001 |
LDL cholesterol (mg/dL) | 114.74±33.02 | 113.41±32.48 | 116.45±33.62 | <0.001 |
Triglyceride (mg/dL) | 132.71±72.26 | 146.52±77.92 | 115.01±59.78 | <0.001 |
HDL cholesterol (mg/dL) | 54.66±13.45 | 51.99±12.62 | 58.07±13.70 | <0.001 |
Systolic blood pressure (mmHg) | 122.65±14.71 | 124.50±13.76 | 120.08±15.49 | <0.001 |
Diastolic blood pressure (mmHg) | 76.44±9.89 | 77.97±9.58 | 74.48±9.93 | <0.001 |
Fasting glucose (mg/dL) | 95.81±18.40 | 97.27±19.92 | 93.92±16.04 | <0.001 |
eGFR (mL/min/1.73 m2) | 90.02±19.64 | 91.19±19.24 | 90.81±20.14 | <0.001 |
Serum creatinine (mg/dL) | 0.96±0.71 | 1.06±0.75 | 0.82±0.62 | <0.001 |
Proteinuria (%) | 202,928 (1.98) | 113,838 (1.98) | 89,090 (1.98) | 0.426 |
eGFR<60 mL/min/1.73 m2 (%) | 459,032 (4.48) | 213,207 (3.70) | 245,825 (5.47) | <0.001 |
Chronic kidney disease (%) | 630,420 (6.15) | 309,360 (5.37) | 321,060 (7.15) | <0.001 |
Metabolic syndrome (%) | 2,281,675 (22.25) | 1,270,105 (22.05) | 1,011,570 (22.52) | <0.001 |
Individual component (%) | ||||
Abdominal obesity | 2,868,480 (27.98) | 1,266,208 (21.98) | 1,602,272 (35.67) | <0.001 |
Hypertriglyceridemia | 3,085,216 (30.09) | 2,163,829 (37.56) | 921,387 (20.51) | <0.001 |
Low HDL cholesterol | 2,023,489 (19.74) | 786,802 (13.66) | 1,236,687 (27.53) | <0.001 |
High blood pressure | 4,454,799 (43.45) | 2,757,750 (47.87) | 1,697,049 (37.78) | <0.001 |
High fasting glucose | 3,120,707 (30.44) | 1,963,828 (34.09) | 1,156,879 (25.75) | <0.001 |
Abbreviations: TC, total cholesterol; LDL, low-density lipoprotein; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate.